NCT06038409

Ketamine Treatment Plans for Chronic Conditions

Understanding the Safety of Home Ketamine Treatment Plans for Chronic Conditions

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: RIVER Foundation · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

Detailed description

Ketamine can be administered in multiple ways (IV, IM, SubQ, and Sublingual, among others), and there have been few if any, studies that have compared the impact of Ketamine at home without any thearpy. The study will identify other treatment modalities used in concurrence with Ketamine. Psychotherapy, music therapy, and acutherapy are some of the most popular. How do these adjunct therapies affect the outcomes of Ketamine treatments? Secondarily, the study will focus on these significant issues to observe the impact of Ketamine treatments and suicidal ideation. Suicidal ideation is multifaceted and is one reason for prescribing off-label Ketamine. Chronic issues such as depression, pain, and anxiety have been identified as underlying causes and may be improvable with Ketamine.

Conditions

• Chronic Pain
• Depressive Disorder
• Anxiety Disorders
• Chronic Disease

Interventions

Type	Name	Description
DRUG	Ketamine	The efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the treatment plan of those with chronic conditions

Timeline

• Start date: 2023-01-01
• Primary completion: 2029-01-01
• Completion: 2029-06-01
• First posted: 2023-09-14
• Last updated: 2024-11-26

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study